Labcorp and EmblemHealth announce strategic collaboration to serve over 3 million members In New York communities

BURLINGTON, N.C., February 22, 2021— Labcorp (NYSE: LH), a leading global life sciences company, and EmblemHealth, one of the nation’s largest nonprofit health insurers, have entered into a strategic collaboration to provide laboratory testing services to the more than 3 million participants enrolled in EmblemHealth plans in New York and New Jersey. The preferred provider agreement allows EmblemHealth to offer its members best-in-class service and easier access to high-quality lab testing.

Labcorp and Circuit Clinical collaborate to bring clinical trials directly to patients and increase access to underrepresented populations

Burlington, NC and Buffalo, NY – February 19, 2021 – Labcorp, (NYSE: LH), a leading global life sciences company, and Circuit Clinical®, a network of physicians and clinical research professionals devoted to and passionate about bringing clinical research to everyone, today announced a collaboration to bring clinical trials directly to patients in the places, and with the people, their communities trust most to deliver healthcare services.

Pacific Biosciences Sequel II Systems deployed to scale-up global viral surveillance initiatives focused on COVID-19

MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) --Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio® Sequel® II Systems. The new systems will expand Labcorp’s capacity to generate thousands of more complete coronavirus genomes from patient samples each week. These data are being used by the United States (U.S.) Centers for Disease Control and Prevention (CDC) to track the spread of existing SARS-CoV-2 variants and detect the emergence of new variants circulating in different geographic regions. Most recently, Labcorp and the CDC utilized PacBio HiFi sequencing data to identify the first known cases of infection from the B.1.351 variant in both South Carolina1 and Virginia2.

Labcorp adds high sensitivity antigen test to screen for active COVID-19 infection

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 17, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of a new laboratory-based antigen test that will help doctors determine if an individual is actively infected with COVID-19.

Labcorp extends relationship with the Department of Defense to provide laboratory services

Burlington, NC – February 16, 2021 – Labcorp (NYSE: LH), a leading global life sciences company, has extended its agreement with the U.S. Department of Defense to provide clinical reference laboratory services to U.S. military personnel and dependents across the globe.

Amy Summy, Chief Marketing Officer of Labcorp, named to Forbes’ CMO Next

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 16, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Amy Summy , executive vice president and chief marketing officer, was recognized on the 2021 Forbes CMO Next list for her leadership during the COVID-19 crisis, while also spearheading the rebranding strategy that highlighted the power of Labcorp’s combined diagnostic and drug development businesses.

Labcorp announces 2020 fourth quarter and full year results and provides 2021 guidance

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 11, 2021-- Labcorp  (NYSE: LH), a leading life sciences company, today announced results for the fourth quarter and year ended December 31, 2020 , and full year 2021 guidance.

Labcorp announces key appointments to oncology leadership team

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 9, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy , MD, MPH, and Robert Phillips , PhD, to its oncology team, advancing Labcorp’s leadership position and capabilities in cancer diagnosis, treatment, and drug development.